NeuroOne Medical Technologies Corp
NMTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.67M
Close$
$-1.04
155.3% downside
Current Fair Value
155.3% downsideOvervalued by 155.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.67 Million |
|---|---|
| Enterprise Value | $15.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.64 |
| Outstanding Shares | 8,661,624 |
Return
| Return on Equity | -189.76% |
|---|---|
| Return on Assets | -115.57% |
| Return on Invested Capital | -199.53% |
Valuation & Multiples
| P/E Ratio | -2.22 |
|---|---|
| PEG | -6.59 |
| Price to Sales | 1.88 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.57 |
| Enterprise Value to EBIT | -1.9 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.98 M
Average shareholder expectationNext Earnings Call
Expected Date
December 15, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$2.79 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 101,500▼ 12.12% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.26%▼ 1.48% |
|---|---|
| Total Invested | $9.14M▼ 3.11% |
| Investors Holding | 32▼ 7.00% |
ESG Score
No data
About NeuroOne Medical Technologies Corp
2,019 employees